...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Two big thank you’s

Nov 24, 2022 01:46PM
2
Nov 24, 2022 03:49PM

Nov 24, 2022 04:33PM
5
Nov 24, 2022 05:54PM
2
Nov 24, 2022 07:41PM
2
Nov 24, 2022 07:53PM

Very good info.

I think Zen used to provide a letter stating an estimated value once a year on it's faq but I no longer see it there. They may have removed it when the shares began trading OTC.

The overcontribution penalties are steep by design, not something you want to stumble into accidentally.

2
Nov 24, 2022 08:40PM

Nov 24, 2022 08:53PM
3
Nov 24, 2022 09:26PM
2
Nov 25, 2022 07:18AM
2
Nov 25, 2022 12:40PM
1
Nov 25, 2022 02:23PM
Share
New Message
Please login to post a reply